Reappraisal of the role of Helicobacter pylori in chronic spontaneous urticaria

Year 2023, Volume: 6 Issue: 6, 1342 - 1349, 29.10.2023

Sinem Örnek Özdemir Emek Özgür

https://doi.org/10.32322/jhsm.1352876

Abstract

Aims: Chronic spontaneous urticaria (CSU) is one of the most prevalent skin disorders. Helicobacter pylori (HP) infection has been linked to CSU, and HP eradication therapy has been questioned as a viable treatment option. However, studies have produced contradictory results. In addition, recent studies suggest that gastritis, rather than HP bacteria, may be responsible for CSU symptoms. Herein, we aimed to ascertain the prevalence of HP infection in CSU, explore associations between HP infection, gastritis, and CSU severity or treatment response in CSU, and investigate the impact of HP eradication therapy on the CSU course.
Methods: We retrospectively analyzed CSU patients who were investigated for HP infection. Patient characteristics, in-clinic urticaria activity scores (ic-UAS) and urticaria control test (UCT) scores, and CSU treatment responses were compared across different patient groups.
Results: The study included 325 CSU patients, of whom 57.2% were HP-positive and 60.9% had gastritis. The mean baseline ic-UAS showed no difference between HP-positive and HP-negative patients (2.55±2 vs 2.45±1.98, p>0.05) or between patients with and without gastritis (2.33±2 vs 2.51±2, p>0.05). HP-positive patients had higher rates of elevated CRP levels (45% vs 29.9%, p=0.023) and ASST positivity (54.8% vs 29.8%, p<0.001). The AH response exhibited a statistically significant increase in HP-positive patients compared to HP-negative patients (78.4% vs 61.2%, p=0.006) and in patients with gastritis compared to patients with no gastritis (76.8% vs 61.3%, p=0.013). There was no difference in response to omalizumab treatment between HP-positive and HP-negative patients (90% vs 86.5%, p=0.528) or between patients with gastritis and patients with no gastritis (91.3% vs 85.3%, p=0.404). No significant difference was observed in response rates to antihistamines or omalizumab between HP-positive patients who had not received eradication therapy and those who had received such therapy (p>0.05).
Conclusion: Over half of CSU patients have been found to be infected with HP. However, the HP bacterium itself, the eradication of HP, or gastritis have no significant effect on CSU severity or treatment response.

Keywords

disease severity, eradication, gastritis, Helicobacter pylori, treatment response, urticaria

References

• Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA(2)LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734-766.
• Magerl M, Altrichter S, Borzova E, et al. The definition, diagnostic testing, and management of chronic inducible urticarias - The EAACI/GA(2) LEN/EDF/UNEV consensus recommendations 2016 update and revision. Allergy. 2016;71(6):780-802.
• Kolkhir P, Munoz M, Asero R, et al. Autoimmune chronic spontaneous urticaria. J Allergy Clin Immunol. 2022;149(6):1819-1831.
• Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420-429.
• Hunt RH, Xiao SD, Megraud F, et al. Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. J Gastrointestin Liver Dis. 2011;20(3):299-304.
• Malfertheiner P, Camargo MC, El-Omar E, et al. Helicobacter pylori infection. Nat Rev Dis Primers. 2023;9(1):19.
• Roesler BM, Rabelo-Goncalves EM, Zeitune JM. Virulence Factors of Helicobacter pylori: a review. Clin Med Insights Gastroenterol. 2014;7:9-17.
• Tebbe B, Geilen CC, Schulzke JD, Bojarski C, Radenhausen M, Orfanos CE. Helicobacter pylori infection and chronic urticaria. J Am Acad Dermatol. 1996;34(4):685-686.
• Di Campli C, Gasbarrini A, Nucera E, et al. Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci. 1998;43(6):1226-1229.
• Cui YL, Zhou BY, Gao GC. A systematic review and meta-analysis of the correlation between Helicobacter pylori infection and chronic urticaria. Ann Palliat Med. 2021;10(10):10584-10590.
• Radenhausen M, Schulzke JD, Geilen CC, et al. Frequent presence of Helicobacter pylori infection in chronic urticaria. Acta Derm Venereol. 2000;80(1):48-49.
• Ozkaya-Bayazit E, Demir K, Ozguroglu E, Kaymakoglu S, Ozarmagan G. Helicobacter pylori eradication in patients with chronic urticaria. Arch Dermatol. 1998;134(9):1165-1166.
• Fukuda S, Shimoyama T, Umegaki N, Mikami T, Nakano H, Munakata A. Effect of Helicobacter pylori eradication in the treatment of Japanese patients with chronic idiopathic urticaria. J Gastroenterol. 2004;39(9):827-830.
• Moreira A, Rodrigues J, Delgado L, Fonseca J, Vaz M. Is Helicobacter pylori infection associated with chronic idiopathic urticaria? Allergol Immunopathol (Madr). 2003;31(4):209-214.
• Valsecchi R, Pigatto P. Chronic urticaria and Helicobacter pylori. Acta Derm Venereol. 1998;78(6):440-442.
• Dauden E, Jimenez-Alonso I, Garcia-Diez A. Helicobacter pylori and idiopathic chronic urticaria. Int J Dermatol. 2000;39(6):446-452.
• Kim HJ, Kim YJ, Lee HJ, et al. Systematic review and meta-analysis: Effect of Helicobacter pylori eradication on chronic spontaneous urticaria. Helicobacter. 2019;24(6):e12661.
• Zheleznov S, Urzhumtseva G, Petrova N, et al. Gastritis Can Cause and Trigger Chronic Spontaneous Urticaria Independent of the Presence of Helicobacter pylori. Int Arch Allergy Immunol. 2018;175(4):246-251.
• Zhang C, Wei Y. Association between Helicobacter pylori-negative peptic ulcer disease and chronic urticaria: a retrospective observational study. Clin Cosmet Investig Dermatol. 2021;14:1637-1643.
• Chen CM, Huang WT, Chang LJ, Hsu CC, Hsu YH. Peptic ulcer disease is associated with increased risk of chronic urticaria independent of Helicobacter pylori infection: a population-based cohort study. Am J Clin Dermatol. 2021;22(1):129-137.
• Chu CY, Zuberbier T. Urticaria and the gut. Curr Opin Allergy Clin Immunol. 2020;20(4):381-385.
• Hawro T, Ohanyan T, Schoepke N, et al. The Urticaria activity score-validity, reliability, and responsiveness. J Allergy Clin Immunol Pract. 2018;6(4):1185-1190 e1.
• Mlynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M. How to assess disease activity in patients with chronic urticaria? Allergy. 2008;63(6):777-780.
• Weller K, Groffik A, Church MK, et al. Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control. J Allergy Clin Immunol. 2014;133(5):1365-1372.
• Kocaturk E, Kiziltac U, Can P, et al. Validation of the Turkish version of the Urticaria Control Test: Correlation with other tools and comparison between spontaneous and inducible chronic urticaria. World Allergy Organ J. 2019;12(1):100009.
• Peleteiro B, Bastos A, Ferro A, Lunet N. Prevalence of Helicobacter pylori infection worldwide: a systematic review of studies with national coverage. Dig Dis Sci. 2014;59(8):1698-1709.
• Liou JM, Malfertheiner P, Lee YC, et al. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut. 2020;69(12):2093-2112.
• Buyukbaba-Boral O, Kucuker-Ang M, Aktas G, Issever H, Ang O. HpSA fecoprevalence in patients suspected to have Helicobacter pylori infection in Istanbul, Turkey. Int J Infect Dis. 2005;9(1):21-26.
• Sari YS, Sander E, Erkan E, Tunali V. Endoscopic diagnoses and CLO test results in 9239 cases, prevalence of Helicobacter pylori in Istanbul, Turkey. J Gastroenterol Hepatol. 2007;22(11):1706-1711.
• Ozaydin N, Turkyilmaz SA, Cali S. Prevalence and risk factors of Helicobacter pylori in Turkey: a nationally-representative, cross-sectional, screening with the (1)(3)C-Urea breath test. BMC Public Health. 2013;13:1215.
• Hook-Nikanne J, Varjonen E, Harvima RJ, Kosunen TU. Is Helicobacter pylori infection associated with chronic urticaria? Acta Derm Venereol. 2000;80(6):425-426.
• Cuevas Acuna MT, Lopez Garcia AI, Paz Martinez D, et al. [Frequency of Helicobacter pylori infection in patients with chronic urticaria of Puebla University Hospital]. Rev Alerg Mex. 2006;53(5):174-178.
• Mogaddam MR, Yazdanbod A, Ardabili NS, Maleki N, Isazadeh S. Relationship between Helicobacter pylori and idiopathic chronic urticaria: effectiveness of Helicobacter pylori eradication. Postepy Dermatol Alergol. 2015;32(1):15-20.
• Dennis MF, Mavura DR, Kini L, Philemon R, Masenga EJ. Association between chronic urticaria and Helicobacter pylori infection among patients attending a tertiary hospital in Tanzania. Dermatol Res Pract. 2020;2020:5932038.
• Gu H, Li L, Gu M, Zhang G. Association between Helicobacter pylori infection and chronic urticaria: a meta-analysis. Gastroenterol Res Pract. 2015;2015:486974.
• Gaig P, Garcia-Ortega P, Enrique E, Papo M, Quer JC, Richard C. Efficacy of the eradication of Helicobacter pylori infection in patients with chronic urticaria. A placebo-controlled double blind study. Allergol Immunopathol (Madr). 2002;30(5):255-258.
• Abdou AG, Elshayeb EI, Farag AG, Elnaidany NF. Helicobacter pylori infection in patients with chronic urticaria: correlation with pathologic findings in gastric biopsies. Int J Dermatol. 2009;48(5):464-469.
• Akashi R, Ishiguro N, Shimizu S, Kawashima M. Clinical study of the relationship between Helicobacter pylori and chronic urticaria and prurigo chronica multiformis: effectiveness of eradication therapy for Helicobacter pylori. J Dermatol. 2011;38(8):761-766.
• Yadav MK, Rishi JP, Nijawan S. Chronic urticaria and Helicobacter pylori. Indian J Med Sci. 2008;62(4):157-162.
• Kohli S, Mahajan VK, Rana BS, et al. Clinicoepidemiologic features of chronic urticaria in patients with versus without subclinical Helicobacter pylori Infection: a cross-sectional study of 150 patients. Int Arch Allergy Immunol. 2018;175(1-2):114-120.
• Campanati A, Gesuita R, Giannoni M, et al. Role of small intestinal bacterial overgrowth and Helicobacter pylori infection in chronic spontaneous urticaria: a prospective analysis. Acta Derm Venereol. 2013;93(2):161-164.
• Hellmig S, Troch K, Ott SJ, Schwarz T, Folsch UR. Role of Helicobacter pylori Infection in the treatment and outcome of chronic urticaria. Helicobacter. 2008;13(5):341-345.
• Elhendawy M, Hagras MM, Soliman SS, Shaker ESE. Positive effect of Helicobacter pylori treatment on outcome of patients with chronic spontaneous urticaria. Am J Clin Pathol. 2021;155(3):405-411.
• Saribas S, Kocazeybek B, Aslan M, et al. Do procalcitonin and C-reactive protein levels have a place in the diagnosis and follow-up of Helicobacter pylori infections? J Med Microbiol. 2004;53(Pt 7):639-644.
• Guo Y, Li HM, Zhu WQ, Li Z. Role of Helicobacter pylori eradication in chronic spontaneous urticaria: a propensity score matching analysis. Clin Cosmet Investig Dermatol. 2021;14:129-136.
• Curto-Barredo L, Archilla LR, Vives GR, Pujol RM, Gimenez-Arnau AM. Clinical features of chronic spontaneous urticaria that predict disease prognosis and refractoriness to standard treatment. Acta Derm Venereol. 2018;98(7):641-647.
• Ayse Ornek S, Orcen C, Church MK, Kocaturk E. An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria. Int Immunopharmacol. 2022;112:109198.
• McCune A, Lane A, Murray L, et al. Reduced risk of atopic disorders in adults with Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 2003;15(6):637-640.
• Cremonini F, Gasbarrini A. Atopy, Helicobacter pylori and the hygiene hypothesis. Eur J Gastroenterol Hepatol. 2003;15(6):635-636.
• Asero R, Ferrer M, Kocaturk E, Maurer M. Chronic spontaneous urticaria: the role and relevance of autoreactivity, autoimmunity, and autoallergy. J Allergy Clin Immunol Pract. 2023; 11(8):2302-2308.
• Schoepke N, Asero R, Ellrich A, et al. Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study. Allergy. 2019;74(12):2427-2436.
• Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid-Grendelmeier P, Grattan CE. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy. 2009;64(9):1256-1268.
• Appelmelk BJ, Simoons-Smit I, Negrini R, et al. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect Immun. 1996;64(6):2031-2040.
• Magen E, Mishal J, Schlesinger M, Scharf S. Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test. Helicobacter. 2007;12(5):567-571.
• Baskan EB, Turker T, Gulten M, Tunali S. Lack of correlation between Helicobacter pylori infection and autologous serum skin test in chronic idiopathic urticaria. Int J Dermatol. 2005;44(12):993-995.
• Hizal M, Tuzun B, Wolf R, Tuzun Y. The relationship between Helicobacter pylori IgG antibody and autologous serum test in chronic urticaria. Int J Dermatol. 2000;39(6):443-445.
• Chiu YC, Tai WC, Chuah SK, et al. The clinical correlations of Helicobacter pylori virulence factors and chronic spontaneous urticaria. Gastroenterol Res Pract. 2013;2013:436727.
• Shakouri A, Compalati E, Lang DM, Khan DA. Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the grading of recommendations assessment, development, and evaluation system. Curr Opin Allergy Clin Immunol. 2010;10(4):362-369.
• Magen E, Mishal J. Possible benefit from treatment of Helicobacter pylori in antihistamine-resistant chronic urticaria. Clin Exp Dermatol. 2013;38(1):7-12.
• Hasal E, Bulbul Baskan E, Yazici S, Aydogan K, Saricaoglu H. Factors related to omalizumab drug survival and treatment responses in chronic urticaria. Int Arch Allergy Immunol. 2022;183(11):1198-1208.
• Zuberbier T, Chantraine-Hess S, Hartmann K, Czarnetzki BM. Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. Acta Derm Venereol. 1995;75(6):484-487.